Published in Stem Cell Week, February 9th, 2009
"Complete response rate was 44% and 56% for refractory and relapsed patients, respectively, with an overall response rate of 52% (32 of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.